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Summary
Objective: To evaluate a technique of autologous chondrocyte implantation (ACI) similar to the other techniques using cell-seeded resorbable
collagen membranes in large articular defects.
Methods: Autologous cartilage was harvested arthroscopically from the lateral trochlear ridge of the femur in ﬁfteen 3-year-old horses. After
culture and expansion of chondrocytes the newly created ACI construct (autologous chondrocytes cultured expanded, seeded on a collagen
membrane, porcine small intestine submucosa) was implanted into 15 mm defects on the medial trochlear ridge of the femur in the opposite
femoropatellar joint. Using two defects in each horse, the ACI technique was compared to collagen membrane alone (CMA) and empty
cartilage defects (ECDs).
Results: Arthroscopic evaluations at 4, 8, 12 and 18 months demonstrated that CMA was signiﬁcantly worse compared to ACI or ECD treat-
ments, with ACI having the best overall subjective grade. Overall raw histological scores demonstrated a signiﬁcant improvement with ACI
compared to either CMA or ECD treated defects and ACI defects had signiﬁcantly more immunohistochemical staining for aggrecan than
CMA or ECD treated defects (with signiﬁcantly more type II collagen in ACI and ECD compared to CMA defects) at 12 and 18 months.
Conclusions: Histologic and immunohistochemistry results from this long-term randomized study are particularly encouraging and demon-
strate superiority with the ACI technique. Although there is no comparable study published with the traditional ACI technique in the horse
(or with such a large defect size in another animal model), the use of a solid autologous cell-seeded-constructed implant would appear to offer
considerable clinical advantages.
ª 2007 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Articular cartilage injuries have limited potential to heal and
if defects are left untreated, may progress to osteoarthritis
(OA)1,2. There are a number of different surgical procedures
that have been used to treat cartilage injuries, with the
ultimate aim of restoration of normal joint function, providing
repair tissue in the defect that resembles hyaline cartilage,
and integration of the repair tissue with surrounding carti-
lage and underlying bone. These surgical techniques can
be divided into two categories as follows: (1) manipulation
of endogenous healing, which usually involves marrow-
stimulating procedures such as subchondral bone drilling,
abrasion arthroplasty and microfracture and; (2) resurfacing
defects with heterologous or autologous cartilage,1This study was funded by Mitek-Dupuy Biologics, Raynham, MA
02767, United States.
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667osteochondral plug autografts and allografts or autologous
chondrocyte implantation (ACI)3,4.
ACI was ﬁrst described in 19944 and the technique has
been widely used in the United States and Europe5e20.
ACI is the only cell-based therapy for cartilage repair that
has been approved by the US Food and Drug Administra-
tion (FDA) for clinical use in the United States (Carticel,
Genzyme, USA) and involves harvesting and expanding
autologous articular chondrocytes from a minor load-bear-
ing area, with re-implantation under a periosteal ﬂap at
the defect site4. The technique, as it has been popularized
in Europe, is the same involving culturing of articular chon-
drocytes and re-implantation in liquid form under a periosteal
ﬂap; the only difference being that cells are cultured by lab-
oratories other than Genzyme.
In an Swedish study using the procedure on femoral con-
dyles, good to excellent long-term results were considered
to occur in 89% of the patients, and eight of 12 biopsy spec-
imens showed ﬁndings consistent with hyaline tissue15.
Other authors, however, have been skeptical with regard
to autologous cartilage implantation being better than other
methods2,8,17. In a study with 2 years follow-up, the improve-
ment provided by ACI was considered to be inferior to that
provided by osteochondral autografting17. On the other
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cal results were excellent or good in 88% vs 69% and arthro-
scopic examination demonstrated excellent or good repairs
in 82% in ACI compared to 34% in mosaicplasty patients, re-
spectively5. A recent paper in 80 patients with a single symp-
tomatic cartilage defect compared the results of ACI and
microfracture. At 2 years both groups had signiﬁcant clinical
improvement. According to the short form health survey (SF-
36) physical component score at 2 years post-operatively,
the improvement in the microfracture group was signiﬁcantly
better than in the ACI group (P¼ 0.004). Biopsy specimens
were obtained from 84% of the patients and histological
evaluation of repair tissue showed no signiﬁcant differences
between the two groups3. In a second recent study it was
pointed out that the patients in the previous study with micro-
fractures had lesions smaller than 4 cm2 and the authors of
the latter study reported (with 5 years follow-up) on a series
of patients with average defect size of 4.9 cm2. At 5 years,
62 patients improved, six reported no change, and 19 wors-
ened19. Reasons for failure with the ACI technique include:
separation of the periosteal ﬂap from the surrounding carti-
lage and hypertrophy in the periosteal ﬂap that required sub-
sequent shaving.
Verigen in Germany (recently acquired byGenzyme) has
developed a technique of ACI that neither requires harvest-
ing or suturing of an autologous periosteal ﬂap, nor are the
cells delivered in a liquid suspension. The technique uses
a resorbable porcine collagen type I/III membrane and autol-
ogous chondrocytes are harvested and culture expanded for
a period of 3e4 weeks prior to seeding on the collagen mem-
brane. The collagen membrane is then attached into the
defect with the cells toward the inside using ﬁbrin adhesive
and gentle pressure. The technique has been registered as
matrix-induced ACI (MACI). A second ‘‘solid’’ form of ACI
has been developed by serum free cultivation of cells com-
bined with the use of another collagen type I/III membrane
called Chondro-Gide and a third is an autologous bio-
engineered graft based on hyaluronan and called Hyalograft
C10,21e24. A special instrument has been developed to
allow implantation of the graft arthroscopically.
This current paper examines a technique similar to other
techniques using cell-seeded resorbable collagen mem-
branes where autologous chondrocytes were culture
expanded, seeded on a collagen membrane [small intestine
submucosa (SIS)] and then re-implanted into large cartilage
defects in the horse.Table
Randomized assignment of hor
Study groups Horse #
I II III d
ECD ACI d J16C
ECD d CMA J17C
d ACI CMA J18C
ECD ACI d J19C
ECD d CMA J33C*
d ACI CMA J21C
d ACI CMA J22C
ECD ACI d J23C
ECD d CMA J24C
d ACI CMA J25C
ECD ACI d J26C
ECD d CMA J35C
ECD ACI d J36C
ECD d CMA J39C
d ACI CMA J42C
I: ECD (empty); II: ACI (cellsþ stapleþmembrane). III: CMA (staplMethod
The Animal and Care Use Committee at Colorado State University (CSU)
approved that all aspects of this study were carried out following good
laboratory practice (GLP) guidelines. Fifteen horses were purchased from
a commercial vendor. Horses were 2e3 years of age (skeletally mature)
and were free of musculoskeletal disease (based on clinical examination
and radiographs). Horses were housed in 15 m2 stalls located at the Ortho-
paedic Research Center at CSU and remained in these stalls except when
undergoing surgery, treadmilling, weighing, or at the time of sacriﬁce.EXPERIMENTAL DESIGNThe horses were randomized for treatment by assignment of horse num-
bers as indicated in Table I. Each 15 mm diameter defect (n¼ 2) in each
horse randomly received one of three treatments: Group I¼ECD (empty car-
tilage defect), Group II¼ ACI (autologous chondrocyte implantation attached
with three absorbable polydioxanone (PDS)/polyglycolic acid (PGA) staples)
and Group III¼ collagen membrane alone [CMA (no cells) attached with
three absorbable PDS/PGA staples]. No horse received the same treatment
in both defects. The study design enabled 10 data points for each of the
three treatment options (it is to be noted that if each horse had an empty de-
fect for one of its two defects, there would be fewer opportunities to evaluate
the ACI and CMA e not more than 15 data points total).CARTILAGE HARVESTOn day 0 of the studies horses had pre-operative medications of 4.5 mg/
kg of phenylbutazone (this was continued once a day for 5 days), as well as
antibiotics (ceftiofur, 2.2 mg/kg IM twice daily for 3 days). A catheter was
placed, the horses pre-medicated with xylazine (0.5e1.1 mg/kg IV) or deto-
midine (5e10 mcg/kg IV) butorphanol (0.02e0.05 mg/kg IV) and then gen-
eral anesthesia was induced with ketamine (2.2 mg/kg IV), and valium
(0.1 mg/kg IV). Anesthesia was maintained with halothane in 100% oxygen
through a semi-closed breathing system. After surgical preparation, and
draping, arthroscopic surgery was done on one randomly selected femoropa-
tellar joint using a previously described technique25. To obtain cartilage for
ACI, approximately 300 mg of articular cartilage was harvested from the
proximal aspect of the lateral trochlear ridge of the femur using Ferris-Smith
intervertebral disc rongeurs (Fig. 1). During the same surgical procedure, ap-
proximately 100 ml of blood was collected from the horse and the harvested
tissue and blood packaged in a speciﬁcally designed insulated transport kit
to be transported overnight from the surgery site to Verigen for processing.
The harvested cartilage was transported in 50 ml of Dulbecco’s Modiﬁed Ea-
gle Medium (DMEM)/F12 transport media.
The ACI construct is a combination biological and devised product com-
prised of cultured autologous chondrocytes seeded onto a porcine SIS col-
lagen membrane. The SIS collagen membrane is currently used in
a product marketed by DePuy Inc. a Johnson and Johnson Company under
the name Restore Orthobiologics Soft Tissue Implant (however, there is a
difference in size between the SIS membrane used in this study and the
Restore product). SIS is a naturally e derived terminally e sterilized avascu-
lar collagen material (primarily type I) that is minimally processed during the
creation of the 4 5 cm membrane. Its laminated construction (10 layers of
individual SIS membranes) provides sufﬁcient mechanical strength andI
ses into treatment groups
Left stiﬂe Right stiﬂe
Proximal Distal Proximal Distal
Biopsy ECD ACI
ECD CMA Biopsy
Biopsy ACI CMA
ACI ECD Biopsy
Biopsy CMA ECD
CMA ACI Biopsy
Biopsy CMA ACI
ECD ACI Biopsy
Biopsy ECD CMA
ACI CMA Biopsy
Biopsy ACI ECD
CMA ECD Biopsy
Biopsy ECD ACI
Biopsy CMA ECD
ACI CMA Biopsy
eþmembrane).
Fig. 1. Arthroscopic images (from an earlier pilot study) of pre (A) and immediately post (B) tissue harvest from lateral trochlear ridge of the
distal femur.
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authors’ believed that the sum of these properties (natural collagen, minimal
processing to preserve inherent biological properties, mechanical strength,
and isotropic) made SIS a good candidate as a membrane to enable autol-
ogous cell-seeded cartilage repair. The cell-seeded SIS collagen membrane
is manufactured in a continuous process by cell culture from enzymatically
digested articular cartilage tissue donated by the patient. Cells were cultured
in DMEM/F12 (1:1 ratio) containing 20% fetal calf serum, 70 mM gentamicin
sulfate, 2.2 mM amphotericin B, and 300 mM L-ascorbic acid (Invitrogen Carls-
bad, CA, USA). After 7 days cells were cultured without antibiotics. When an
adequate number of cells (20 106) are available the cells are seeded onto
the SIS collagen membrane and incubated for approximately 2e4 days to per-
mit cell adhesion to the membranes substrate [Fig. 2(A) and (B&C) also illus-
trates the constructs at 3 weeks]. Approximately 4weeks post-cartilage biopsy
the newly created ACT, as well as samples of the SIS CMA without cells was
shipped overnight from Verigen back to CSU for immediate implantation. The
average seeding density was 1 million cells/cm2 and these were seeded into
a 20 cm2 SIS collagenmembrane. Based on the studies performed by the sec-
ond author some years previously, approximately 50% (0.5 million cells/cm2)
were still viable after the 72e96 h required for international shipment inFig. 2. Horse chondrocytes were seeded (5 106 cells/cm2) onto
SIS scaffolds, cultured in vitro for up to 3 weeks in chondrocyte
growth media containing 10% fetal bovine serum (FBS), and stained
with H&E and safranin-O (SO). Histological analysis conﬁrmed that
chondrocyteswithin 3 daysattached to the surfaceof theSISscaffold
(Fig. A, H&E), and after 3 weeks had proliferated (Fig. B, H&E)
and maintained a chondrocytic phenotype (Fig. C, SO). Note the
multi-layer laminate construction of the SIS scaffold (Fig. A).
Magniﬁcation 100.refrigerated conditions which mean that at the time of implantation approxi-
mately 10 106 cells were implanted. The study time line is depicted in Table II.IMPLANTATION OF CARTILAGE CONSTRUCTSApproximately 4 weeks post-cartilage biopsy via arthroscopy, the horses
were re-anesthetized and a cranial arthrotomy approach (over the medial
trochlear ridge of the femur) made to the femoropatellar joint. The arthrotomy
was performed in the joint contra-lateral to the joint from which articular carti-
lage was harvested. Using custom 15 mm biopsy punches, an impression in
the articular cartilage corresponding to the defect site was made in the medial
trochlear ridge (two defects per joint and one joint per horse), with aminimumof
7 mmseparating the two defects (Fig. 3). Amanual curettewas used to remove
all cartilage within the two outlying defects, care being taken to leave the calci-
ﬁed cartilage intact. The site was ﬂushed with a sterile epinephrine and normal
saline solution if needed to control bleeding (at a concentration of 1/1000).
Both the ACI and CMA were sized using similar 15 mm biopsy punches
and then afﬁxed into the defects using three absorbable PDS/PGA staples
(Fig. 4). The use of these staples was compared against suture ﬁxation in
an earlier pilot study. The use of staples was quicker and technically easier
than suturing (approximately 5 vs 20 min) and there was no difference with
construct security at follow-up examinations. Three pairs of holes (six holes
per defect) were created to receive the PDS/PGA staples using a custom de-
signed slap hammer device. The staples were then delivered using a second
custom designed slap hammer device. The defects that were designated as
empty chondral defects did not have any holes created. The arthrotomy in-
cision was closed with a layer of 2-0 absorbable suture in the joint capsule,
separate layers in the deep and superﬁcial fascia were closed with 0 absorb-
able sutures, and the skin was closed using simple interrupted sutures of
2-0 nylon and a stent bandage sutured over the incision. No braces, slings
or external ﬁxation devices were used at any point post-operatively during
the study. The overall project scheme is illustrated in Fig. 5.3, 6, 12 AND 18-MONTH POST-CONSTRUCT IMPLANTATION
ARTHROSCOPIESAt approximately 3, 6, and 12 months after implantation, diagnostic arthros-
copy was performed on both femoropatellar joints to examine the defects, as
well as the donor defect site (Tables II and III). During the 12-month procedure,
nine horses were euthanized and the joints preserved for gross and histological
analysis; the remaining six horseswere survived for an additional 6months (i.e.,
18months post-implantation) andhaddiagnostic arthroscopyandeuthanized at
this time. Horses were euthanized according to a pre-determined schedule to
ensure equal treatment group size at both the 12- (n¼ 6 for each treatment)
and 18-month (n¼ 4 for each treatment) time points.RADIOGRAPHSRadiographic examinations were conducted at seven time periods in the
study as follows: (1) at initial check-in; (2) approximately 1 week post-tissue
harvest arthroscopy; (3) approximately 1 week post-construct implant arthrot-
omy; (4) approximately 1 week before the 3-month post-construct implant
arthroscopy; (5) approximately 1 week before the 6-month post-construct
implant arthroscopy; (6) approximately 1 week before the 12-month post-
construct implant terminal arthroscopy (n¼ 9 horses); and (7) approximately
1 week before the 18-month post-construct implant terminal arthroscopy
(n¼ 6 horses). In addition, high-detail radiographs of the repair area (Faxitron
Table II
Exercise protocols for 18 months
Study week Duration Activity
Week (3) 7 days Stall rest
Week (2) 7 days Stall rest
Week (1) 7 days Stall rest
Week 0 Unilateral biopsy surgery/stall rest
Week 1 7 days Stall rest
Week 2 5 days Hand walk at 5 min/day
Week 3 5 days Hand walk at 10 min/day
Week 4e8 Unilateral arthrotomy defect creation/stall rest
Week 9e16 Hand walk progressing each week for 5, 10, 15 and 20 min through week 12. Then treadmill trot for
2 min during week 13 and 5 min for weeks 14e16. All at 5 days per week
Week 17e19 Stall rest
Week 20e21 10 days Hand walk 10 min week 20, and 15 min week 21 at 5 days per week
Week 22e29 Treadmill trot 2 min week 22, 5 min weeks 23e25, 8 min weeks 26e27 and 10 min weeks 28e29.
All at 5 days per week
Week 30e34 6-month re-look bilateral arthroscopy/stall rest weeks 31d34
Week 35e38 20 days Treadmill 6 min trotegallopetrot (2 min each) at 5 days per week (trot¼ 8e12 mph, gallop¼ 25e33 mph)
Week 39e46 40 days Treadmill 6 min trotegallopetrot (2 min each) at 5 days per week (trot¼ 8e12 mph, gallop¼ 35e38 mph)
Week 47e50 28 days Stall rest
Week 51e55 25 days Treadmill 6 min trotegallopetrot (2 min each) at 5 days per week (trot¼ 8e12 mph, gallop¼ 35e38 mph)
Week 56e60 12-month re-look bilateral arthroscopy (5/27), stall rest weeks 57e60
Week 61e64 20 days Treadmill 6 min trotegallopetrot (2 min each) at 5 days per week (trot¼ 8e12 mph, gallop¼ 35e38 mph)
Week 65e72 40 days Treadmill 6 min trotegallopetrot (2 min each) at 5 days per week (trot¼ 8e12 mph, gallop¼ 35e38 mph)
Week 73e76 28 days Stall rest
Week 77e83 35 days Treadmill 6 min trotegallopetrot (2 min each) at 5 days per week (trot¼ 8e12 mph, gallop¼ 35e38 mph)
Week 84 18-month re-look bilateral arthroscopy and euthanasia
670 D. D. Frisbie et al.: Equine ACT via a collagen membraneimages) were made post-tissue collection, but prior to sectioning bones for
histological processing and examined.12- AND 18-MONTH POST-IMPLANTATION PROTOCOL
AND OTHER OUTCOME PARAMETERSDaily observations
Throughout the study, animal care personnel assessed the horses for
daily comfort, movement, and respiratory character. An SOP was estab-
lished for animal care personnel to determine if an animal needed further
evaluation and treatment order by a study veterinarian.Fig. 3. Typical view of two 15 mm defects on medial trochlear ridge,
demonstrating spatial relationship. The insert also shows intact
blood vessels coursing below the calciﬁed cartilage in the lower
half of the defect while disruption of the vessels in the upper half
of the defect is occurring secondary to partial penetration of the cal-
ciﬁed cartilage layer. This defect is not in one of the study animals
but is used to demonstrate ease of identifying penetration of the
calciﬁed cartilage.Lameness evaluations
Lameness evaluations were performed before the tissue biopsy and im-
plantation, and approximately every 4 weeks thereafter until the 3-month ar-
throscopy (excluding one lameness examination 2 weeks post-implantation).
After the 3-month arthroscopy, the lameness examinations were performed
approximately every 2 months for the duration of the project. These exami-
nations included baseline movement (lameness graded 0e5, where 0 is nor-
mal), the presence of synovial effusion in the joints (grade 0e4), range of
motion (0e4) and ﬂexion tests (0e4) of the hind limb.
Exercise
Horses were exercised approximately 5 days a week according to the
schedule (out to 18 months) depicted in Table II. This is a standard rehabil-
itation protocol for our research program and involves progression from walk-
ing to galloping.Fig. 4. Example of stapled (A) constructs from an earlier Pilot study
and insert ﬁgureofabsorbablePDS/PGAstaple (w4 mmtip-to-tip) (B).
Fig. 5. Diagram of tissue harvest site (A) which was followed by
processing and construct creation at Verigen. Four weeks later
the opposite joint had two 15 mm defects created (B) down to the
level of the calciﬁed cartilage (C). The construct was stapled in
place using three absorbable PDS/PGA staples (D and E).
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After euthanasia, a necropsy was performed followed by a detailed exam-
ination of the stiﬂe. Gross/macroscopic observations of the defect and joint
surface were made of both femoropatellar articulations, including presence
of osteophytes and secondary osteoarthritic change, articular surface integrity
contour and congruity, any injury to opposing articular surface, level of repair
ﬁll in defect site based on surrounding ‘‘normal’’ cartilage surface (0e4 for
even with, proud, below, dislodged, or absent [bone exposed], respectively),
any irregularity of repair tissue surface, ﬁrmness of the repair tissue when pal-
pated with a probe and compared to surrounding normal cartilage (0e4 for
none, slight, mild, moderate, and marked ﬁrmness, respectively), attachment
of cartilage e this category describes the degree of repair tissue attachment
to the surrounding normal articular cartilage (0e4), attachment of bone e
describing the degree of repair tissue attachment to the underlying bone
(0e4), the area of repair tissue ﬁlling the defect expressed as a percentage,
and volume of repair tissue ﬁlling the defect expressed as a percentage and
examination of synovial membrane (0e4 for normal, slight, mild, moderate,
and severe inﬂammatory change, respectively).
Synovial membrane was collected to be submitted for hematoxylin and
eosin (H&E) examination. Faxitron images were graded by an individual
unaware of the treatment groups for, sclerosis (presence or absence of
subchondral bone sclerosis in the area of the chondral defect as com-
pared to adjacent radiographic bone densities on a 0e4 scale, absent
to severe, respectively), lysis (presence or absence of bone lysis in the
perceived area of the chondral defect as compared to adjacent radio-
graphic bone densities using a similar 0e4 scale), subchondral bone irreg-
ularities (presence or absence of subchondral bone irregularities in the
perceived are of the chondral defect on a similar 0e4 scale). A total Faxi-
tron score was also calculated by summing each of the categories allow-
ing a maximum score of 12.
Histology and immunohistochemistry
After necropsy procedures were completed, the tissues were trimmed
using a standard band saw and Exakt bone saw with a diamond chip blade
(Exakt Technologies, Oklahoma City, OK, USA). The defect was trimmed to
ﬁt in histological cassette and the specimens ﬁxed in 10% neutral buffered
formalin for a minimum of 2 days. Bone samples were then decalciﬁed
and processed with a custom procedure for large, thick bone samples.
Both cartilage and bone samples were then embedded in parafﬁn and sec-
tioned at 5 mm. The bone and cartilage samples were sectioned at two levels
within the defect area as follows: the ﬁrst level of histological samples was
taken from an area approximately 3 mm and the second level 8 mm from
the proximal edge of the defect. Both samples had ample surrounding tissue
to allow evaluation of repair tissue integration. Equine trachea was used as
a positive control for safranin-O fast green staining (SOFG).
The cartilage and bone samples were stained with H&E, toluidine blue, and
SOFG.Fixationof the implants, thehost response to the implants, and thequal-
ity of the repair tissue were determined microscopically by a histopathologist
unaware of treatment group assignments. A modiﬁed histological grading
system26,27 was used to generate scoring for non-parametric analysis of thethree treatment groups (Table IV). Quantitative histomorphometry was also
performed using a commercial software program [Image-Pro Plus (version
4.5.1.29) Media Cybernetics Inc., Silver Spring, MD 20910, USA].
The synovial tissues were processed using standard programs for soft tis-
sues, embedded in parafﬁn, and sectioned at 5 mm. These sections were
stained using H&E. The synovial membrane sections were scored for cellular
inﬂammation, intimal hyperplasia, subintimal edema, subintimal ﬁbrous and
increase vascularity using a 0e4 scale (0 representing normal and 4 severe
change) by an observer unaware of treatment assignments.
Immunohistochemical analysis was performed on fresh frozen sections
harvested from two locations adjacent to histologic harvest sites. For immu-
nohistochemical examination, antibodies against type I and II collagens,
aggrecan, and the chondrocyte speciﬁc protein S-100 were used. The
methods for staining and preparation of negative controls have been previ-
ously described by the authors28. The immunohistochemistry sections
were graded by a histologist unaware of the treatment assignments using
a 0e3 scale: a grade 0 indicated that immunoreactivity was not present,
a grade 1 represented at least some immunoreactivity was present, a grade
2 indicated that immunoreactivity extended focally either from top to bottom
or from side to side in the graft, and a grade 3 indicated that immunoreactivity
involved the entire graft (top to bottom and side to side).
Data analysis
Data were analyzed using one or a combination of descriptive statistics,
non-parametric frequency tables, and mixed model analysis of variance
(AOV). When main or interaction effects had P-values that were considered
signiﬁcant (P-value< 0.05) or a trend (P-value<0.10 and >0.05) then indi-
vidual comparisons were made using the least square means procedure.
The horse was considered a random effect in the AOV models. A commer-
cially available software package was used for all analysis, SAS version 8E
(Cary, NC, USA). Graphs were represented by their means 1 standard
error of the mean (S.E.M.) with statistical signiﬁcance noted by letter conne-
cting the statistical comparison.ResultsCARTILAGE HARVESTNo complications were encountered from the harvest of
autologous articular cartilage samples and approximately
300 mg of tissue was easily obtained from the lateral troch-
lear ridge of the femur. Follow-up arthroscopy at 12 or 18
months study period demonstrated a nominal amount of tis-
sue formed in the harvest sites. The clinical examination
showed that for all time periods each of the clinical param-
eters in the biopsy limb was on average, below grade 1 in-
dicating less than a slight change in any of the parameters.IMPLANTATION OF CARTILAGE CONSTRUCTSNo signiﬁcant technical problems were encountered at
the time of construct implantation. Punctuate bleeding
was noted in one of the 30 defects during creation: the
area was conﬁned to <10% of the total defect area and
was stopped using local epinephrine and based on gross
photographs of repair tissue, did not impact later repair
tissue formation. Slight lifting from the base of the defect
and retraction of the implanted construct from the edge of
the defect margin (<1 mm retraction from the defect margin
for under 40% of the defect circumference) occurred in one
location (Fig. 6). The retraction appeared to be secondary to
staple placement, causing increased tension in the area of
construct retraction, but based on arthroscopic follow-up
and gross observations, when retraction was noted, no
long-term differences were observed (Fig. 6).3-, 6-, AND 12-MONTH POST-CONSTRUCT IMPLANTATIONNo complications or signiﬁcant abnormalities were en-
countered during the arthroscopic evaluations of either the
biopsy or implantation joints of any of the horses. Overall
Table III
Grading criteria for arthroscopic evaluation
Cartilage attachment e This category describes on average the defect repair tissue attachment with the surrounding normal cartilage. Possible
responses were:
0¼Normal attachment
1¼Moderate attachment
2¼Mild attachment
3¼Slight attachment
4¼No attachment
Bone attachment e This category describes the ﬁrmness of the repair tissue attachment to the bone at the base of the defect. Possible re-
sponses were:
0¼Normal attachment
1¼Moderate attachment
2¼Mild attachment
3¼Slight attachment
4¼No attachment
Firmness e This category describes on average the ﬁrmness of the repair tissue to normal surrounding articular cartilage based on palpation
with a microscopic probe. Possible responses were:
0¼Similar to surrounding normal articular cartilage
1¼Slightly soft compared to normal surrounding articular cartilage
2¼Mildly soft compared to normal surrounding articular cartilage
3¼Moderately soft compared to normal surrounding articular cartilage
4¼Marked softening compared to normal surrounding articular cartilage
Blood e This category describes the presence or absence of hemorrhage associated with the defect area or its periphery. Possible responses
were:
1¼ Fresh blood: active hemorrhage at time of surgery
2¼Old blood: no active hemorrhage at the time of surgery
3¼No blood visualized at the time of surgery
Shape e This category describes the margin of the defect as it relates to the original geometry at time 0 (creation). Possible responses were:
0¼No apparent increase in damage tissue beyond original defect margins
1¼Degeneration of tissue beyond original defect margins
Grade e This category describes the overall subjective evaluation of the repair tissue by the evaluator. Criteria used to determine the grade
were:
(1) Attachment of repair tissue to the surrounding normal articular cartilage
(2) Level (height) and undulation of the repair tissue surface as compared to the surrounding normal articular cartilage
(3) Color of the repair tissue, where white homogenous tissue without a ﬁbrous like appearance is used as the ‘‘gold standard’’.
Possible responses were:
0¼ Tissue not present to grade
1¼Poor
2¼ Fair
3¼Good
4¼Excellent
Level e This category describes the level of repair tissue ﬁlling in association with the surrounding normal articular cartilage. Possible re-
sponses in relation to the surrounding normal articular cartilage were:
1¼Mildly recessed
2¼Slightly recessed
3¼ Leveled
4¼Slightly elevated
5¼Mildly elevated
6¼Moderately elevated
Color e This category describes the color of the repair tissue. When repair tissue is characterized by two colors, the predominate color is
indicated ﬁrst. Possible responses were:
1¼Red
2¼White/red
3¼Yellow
4¼Yellow/white
5¼White/yellow
6¼White
Surface e This category describes the relative undulation of the repair tissue surface. Possible responses were:
1¼Non-undulating
2¼Slightly undulating
3¼Mildly undulating
4¼Moderately undulating
Staple e This category describes if a PDS/PGA staple was visible to the observer. Possible responses were:
0¼Absent
1¼Present
‘‘.’’¼No staple was used, so data were not included in statistical calculation
Better e This category compares which of a given defect in a joint has subjectively more desirable repair tissue tilling. Possible responses
were:
1¼Better
2¼Worse
Table IV
Modified subjective histopathologic grading system for evaluation
of repair
Category Score
Nature of the repair tissue (include average thickness of reparative
cartilage)
Hyaline cartilage 4
Hyaline-like cartilage 3
Mostly ﬁbrocartilage 2
Mostly non-cartilage 1
Non-cartilage only 0
Matrix staining
Normal or nearly normal staining 3
Moderate (or increased) staining 2
Slight staining 1
None 0
Structural integrity (morphologic zone reconstitution)
Normal structure 2
Slight disruption 1
Severe disruption 0
Surface regularity
Smooth and intact 3
Superﬁcial, horizontal lamination 2
Slight disruption, ﬁssures 1
Severe disruption, ﬁbrillation 0
Filling of the defect
100% 3
75e100% or >100% 2
50e75% 1
<50% 0
Bonding to host tissue: integration with adjacent cartilage
Bonded 2
Partially bonded 1
Not bonded 0
Bonding to host tissue: integration with underlying subchondral bone
Bonded 2
Partially bonded 1
Not bonded 0
Degenerative changes of the repair tissue
Severe degeneration 3
Normal cellularity and cell morphology 2
Mild hypocellularity and cell cluster 1
Moderate hypocellularity and cell degeneration 0
Degenerative changes in an adjacent cartilage
Normal cellularity 3
Slight hypocellularity and cell morphology 2
Moderate hypocellularity and cell degeneration 1
Severe degeneration 0
Maximum score 25
Fig. 6. Implantation picture of defect with construct edge retraction
at implantation (A), but without long-term arthroscopic ramiﬁcations
at 12 months (B).
673Osteoarthritis and Cartilage Vol. 16, No. 6the repair tissue attachment to surrounding normal cartilage
and bone (independent of defect treatment) was good but
slightly less than the normal (grade 1 of 4 where 4 is com-
pletely detached). Signiﬁcant difference was seen over time
related to cartilage and bone attachment of the repair tissue
characterized by progressively better attachment up to 12
months followed by a decrease in attachment in the CMA
treated defects. The overall arthroscopic grade (fair to
good, with the ACI treatment group having the best average
score) also demonstrated that CMA was signiﬁcantly worse
compared to ACI or ECD treatments on average, indepen-
dent of time or defect location (Fig. 7). On average, inde-
pendent of the defect treatment, the ﬁrmness of the repair
tissue was found to be mildly moderately softer on average
compared to the surrounding articular cartilage. Nosigniﬁcant differences were noted for ﬁrmness, presence
of blood, shape, level or color in association with the loca-
tion of the defect (proximal or distal) treatment (ECD,
CMA, and ACI) or study period. The signiﬁcant differences
held throughout to the 18-month period.RADIOGRAPHIC EXAMINATIONSAll radiographic examinations of the stiﬂes were normal
at the beginning of the study. Subjective radiographic
changes consisting of areas of radiolucency associated
with the subchondral plate and staple placement, as well
as areas of sclerosis were observed. These abnormalities
were noted throughout the study in areas where defects
were created and were subjectively graded and analyzed
based on high-detail radiographs (Faxitron images) at the
end of the study. There were signiﬁcant changes based
on treatment group for lysis (Fig. 8) and sclerosis with
CMA treated defects at 12 months having the most patho-
logic scores.
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Fig. 7. Plot of overall arthroscopic grade and treatment group. Different letters indicate a signiﬁcant difference between groups averaged over
time. Lower panel shows arthroscopic view of representative repair tissue from each treatment group of study horses at 3- and 12- month time
points. The letters on the photos could not be changed due to GLP requirement, ACT¼ACI.
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3
4
ACI
CMA
ECD
b
y
s
i
sLimbs from which biopsies were taken from the femoro-
patellar joint only showed a slight (<grade 1) degree of
lameness beginning 2 months following biopsy. Limbs con-
tainingdefects/implanted joints demonstratedasigniﬁcant in-
crease in lameness, response to ﬂexionandsynovial effusion
scores at the ﬁrst time point post-defect creation/implantation
and signiﬁcantly improved throughout the remainder of the
study. Because two different treatment groups were in each
joint/limb, differentiating which treatment group may have
contributed to a lameness is not possible and no patterns
appeared to exist throughout the study.a a
a
LPOST-MORTEM TISSUE EXAMINATIONS12 Mo 18 Mo
0
1 a a
Months
Fig. 8. Plot of Faxitron lysis score by study period and treatment
group. Different letters indicated signiﬁcant differences averaged
over time.There was no infection in any joints and no signiﬁcant dif-
ference in the amount of secondary osteoarthritic change in
the joints (OA change was only noted in 2/15 biopsy and
1/15 treated joints). Likewise, there was no signiﬁcant differ-
ence noted between the groups with regard to articular dam-
age to the opposing surface. Only 3/30 joints had some
damage noted and it was considered to be not clinically rele-
vant. No signiﬁcant differences were noted in the degree of
synovial inﬂammation, with the highest average score being
675Osteoarthritis and Cartilage Vol. 16, No. 60.7 0.2. One horse had a loose body in a biopsy/donor joint
and this was considered to be likely from a harvested carti-
lage fragment that was not retrieved at the time of surgery.
Speciﬁc examination of the repair tissue in the defect
showed no signiﬁcant difference in repair ﬁll compared to
the surrounding normal cartilage based on treatment group,
although on average the proximal defects had inferior carti-
lage attachment (slight compared to mildly less than what
was expected for normal tissues) and defect ﬁlling com-
pared to the distal location. The earlier weight-bearing, and
therefore harsher environment of the proximal compared
to the distal location, most likely explains this ﬁnding. No sig-
niﬁcant difference was noted in repair tissue ﬁrmness, repair
tissue surface irregularities or attachment to bone in any
analysis. The ﬁrmness of the tissue on average was graded
to be mildly less than normal tissue for ACI and ECD treated
defects, but moderately less than normal tissue for CMA,
with mild surface irregularities in all treatment groups.HISTOLOGY AND IMMUNOHISTOCHEMISTRYSynovial membrane histology
Cellular inﬁltration scores (perivascular mononuclear
cells) were as follows: ACIþCMA¼ 2.7 0.41, ECD and
CMA¼ 1.54 0.37, and ECDþ ACI¼ 0.86 0.37. It is
note worthy that two treatment groups would have been
contributed to this score although even with this limitation
it was possible to conclude that the cellular inﬁltration
scores were highest when CMA was present in the defects
and lowest when ACI was present.
Repair tissue histology and immunohistochemistry
Analysis of the overall raw histological scores demon-
strated a signiﬁcant improvement with ACI compared to ei-
ther CMA or ECD treated defects independent of location
(Figs. 9 and 10). The nature of the repair tissue was
graded as being more hyaline-like in the ACI treated
defects (and the overall histology score was signiﬁcantly
improved) compared to the CMA and ECD treated defects.
Likewise the surface regularity was signiﬁcantly worse inFig. 9. Histologic photomicrographs of repair tissue at 18 months for ACI
ﬁcation and each insert showthe CMA compared to either the ACI or ECT treated de-
fects (Fig. 10). Better bonding of the repair tissue to the
surrounding articular cartilage was noted in the ACI and
CMA treatment groups at 18 months compared to the
ECD treated defects (there was deterioration of bonding
in ECD at 18 months compared to 12 months). The bond-
ing was also noted to deteriorate in the ECD treated
defects when the 12- vs the 18-month tissues were com-
pared, while the other treatment groups improved (ACI)
or did not signiﬁcantly change (CMA) (Fig. 9). It is of inter-
est that during the course of 18 months the calciﬁed carti-
lage was reabsorbed and replaced by bone. In most
defects the subchondral bone plate was still present. In
all defects a subchondral bone plate of some form is pres-
ent but it is typically not thick when it is created in normal
joints. There was no signiﬁcant difference noted in SOFG
staining although the matrix staining with toluidine blue de-
creased signiﬁcantly for all treatment groups between 12
and 18 months. The level of defect ﬁll was not signiﬁcantly
different between the treatment groups, although ACT
treated defects had the highest numeric score. Bonding
of the repair tissue to the bone did not show differences,
but similar trends were seen as compared to the repair
tissue bonding to the articular cartilage. There was no sig-
niﬁcant difference in cellular morphology noted for any sta-
tistical comparisons in either the repair or surrounding
host tissues. Signiﬁcant differences were not seen in the
quantitative histomorphometric analysis (Table V).
Results of immunohistochemical analysis indicated that
ACI and ECD had signiﬁcantly more type II collagen when
compared to the CMA treated defects and signiﬁcantly
more aggrecan was noted in the ACI compared to either
the CMA or ECD treated defects (Figs. 11 and 12). No other
signiﬁcant differences were noted.Discussion
The therapeutic strategy of ACI seems to have been im-
proved recently by the use of biocompatible scaffolds
which allow better ﬁxation of the cells inside the defect
while retaining the original cellular phenotype2,29,30., CMA and ECD. Arrows indicate defect margins on the 2 magni-
s a 10 magniﬁcation.
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Fig. 10. Plots of histologic grading for tissue type, surface regularity, repair tissue bonding to surrounding cartilage (bond-C), and total histol-
ogy score (sum of all response categories) by treatment group and by time post-implantation. There was no difference between 12 and 18
months, so these ﬁgures represent all defects.
676 D. D. Frisbie et al.: Equine ACT via a collagen membraneAlthough the most common adverse event reported with
ACI is intra-articular adhesions (2%),31 the next most com-
mon adverse events include detachments/delamination
and hypertrophy of the periosteum. The cartilage registry
report, an international multi-center observation assess-
ment of patients treated with ACI has revealed by patient
assessment that 78% of all defects treated with ACI had
improvement, and 81% of isolated femoral condyle defects
had improved32.
The increased cellular inﬁltration scores in the synovial
membrane from joints in which CMA was present imply
that there is more reaction to the porcine collagenmembraneTable V
Histomorphologic and subjective histologic analysis of repair tissue at b
Different letters indicate a statistical difference between groups within a ro
in the histology outcome parameters with the exception
Histomorphologic analysis of repair tissue
% Repair ﬁlling tissue defect
% Fibrous tissue in total repair tissue
% Fibrocartilage in total repair tissue
% Hyaline cartilage in total repair tissue
% Calciﬁed cartilage in total repair tissue
Subjective histology scores
Nature of the repair tissue
Matrix staining
Structural integrity
Surface regularity
Filling of the defect
Bonding to host tissue: integration with adjacent cartilage
Bonding to host tissue: integration with underlying subchondral bone
Degenerative changes of the repair tissue
Degenerative changes of adjacent cartilage
Totalwithout the cellular cover. This conclusion is based on joints
where there was an empty defect and an ACI defect having
low scores compared to the other two groups of joints that
contained a CMA as one of the treatments. Previous
work33 has demonstrated that porcine SIS is not an acellular
collagenous membrane and contains porcine DNA and the
potential for such reaction in humans would tend to argue
for choosing another membrane.
The technique used in this equine study resembles the
MACI approach, the principal difference being that the
MACI chondrocytes are seeded on a porcine collagen
type I/III membrane, whereas the construct we used isoth 12 and 18 months reported by treatment group. Mean S.E.M.
w. No significant effect of time was seen between 12 and 18 months
of bonding to surrounding cartilage (see Fig. 10)
Empty chondral
defect
Collagen
membrane
Autologous chondrocyte
transplant
60.6a 62.2a 64.8a
59.3a 53.6a 51.3a
35.6a 38.8a 41.9a
5.0a 4.9a 6.4a
0.9a 0a 0a
1.8a 0.2 1.3b 0.2 1.8a 0.2
1.2a 0.1 1.1a 0.1 1.2a 0.1
0.8a 0.1 0.6a 0.1 0.8a 0.1
1.7a 0.2 0.9b 0.2 1.9a 0.2
1.6a 0.2 1.6a 0.2 2.0a 0.2
1.2a 0.1 1.5b 0.1 1.8b 0.1
1.6a 0.1 1.6a 0.1 1.9a 0.1
2.0a 0.0 2.0a 0.0 2.0a 0.0
2.0a 0.0 2.0a 0.0 2.0a 0.0
13.6a 0.6 12.8a 0.6 15.4b 0.6
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Fig. 11. Plot of immunohistochemistry results for both type II collagen and aggrecan for the repair tissue or ‘‘graft tissue (G)’’ by treatment
groups. Different letters indicate a statistical difference between groups averaged over time.
677Osteoarthritis and Cartilage Vol. 16, No. 6seeded on a collagen membrane derived from 10 layers of
porcine SIS. In previous work of the authors suturing of the
collagen membrane was compared to the use of absorbable
PDS/PGA staples. Both methods provided good ﬁxation,
but suturing is much more tedious and time consuming
and is more difﬁcult to adapt to arthroscopic technique in
human clinical patients34.
There is minimal follow-up published with other cell-
seeded resorbable membranes, but it was the subject of
a report at the ﬁfth International Cartilage Research Society
(ICRS) Symposium in 2004 where the authors described an
arthroscopic technique. They presented 40 defects in 36
patients and had re-assessed the ﬁrst 20 knee joints with
a mean follow-up of 24 months (minimum 12 and maximum
36 months)35. All patients improved after surgery and at
clinical evaluation, the Modiﬁed Cincinnati Knee Score im-
proved from a baseline value of 2.9 1.1 to a score of
8.1 1.4, 8.7 1.0, and 9.3 0.8 at 12, 24, and 36 months,Fig. 12. Representative pictures (2) of ACI, CMA and ECD treatrespectively. The authors considered that the arthroscopic
technique was easier and faster and gave a quicker func-
tional recovery, reduced hospital stay, and better compli-
ance with the surgical and rehabilitative procedures. They
also considered that the mechanical characteristics of the
collagen membrane were helpful, as the scaffold is ex-
tremely resistant to tears, even after prolonged exposure
to arthroscopic ﬂuids. As mentioned previously, an arthro-
scopic technique has also been described for the Hyalograft
C procedure, but it has been noted that there are technical
limitations in treating lesions located in the patellar groove,
posterior portion of the femoral condyles, or the tibial pla-
teau10. In a cohort study of 67 patients, 97% of the patients
improved, based on their subjective evaluation, 94% had
improvement in quality of life, 87% of the patients improved
in a knee functional score and arthroscopic evaluation of
cartilage repair showing 96.7% biologically acceptable.
They also noted that on histologic assessment of theed defects stained for aggrecan (A) and type II collagen (B).
678 D. D. Frisbie et al.: Equine ACT via a collagen membranegrafted site, the majority of the specimens were considered
hyaline-like23.
This current study allowed us to evaluate a technique
closely resembling MACI in large defects in an equine
model. As has been noted before, the major indication for
ACI is symptomatic, large full-thickness chondral lesions lo-
cated on the femoral condyle and trochlear groove, includ-
ing osteochondritis dissecans (OCD)31. The horse gives us
the opportunity to emulate large defects such as are treated
in humans with ACI. While it is recognized that most clinical
human defects are in loaded areas on the medial femoral
condyle, this model used the femoral trochlea in part be-
cause of the ability to create two 15 mm diameter defects
in one joint and decrease the number of horses. The load-
ing is different in the patellofemoral articulation but is still
signiﬁcant and the control defects are in the same location.
Furthermore, loading studies conducted in the defect loca-
tions suggest that the proximal location represents an
area that is consistently loaded at all levels of exercise.
This is in contrast to the distal location which is loaded
based on the exercise regime of the horse in particular,
this area only shows contact when the joint is at or equal
to 120 of ﬂexion. The exercise regime followed in the cur-
rent study was designed to provide minimal loading of the
distal defect until about 4 months post-treatment based on
ﬂexion angles. The authors have also studied defects on
the medial femoral condyle (the most common location
treated with ACI) in the evaluation of subchondral microfrac-
ture28,36. The defects on the medial femoral condyle are
1 cm2. The thickness of the cartilage in the horse is also
comparable to that of humans37.
Arthroscopic evaluation enabled us to follow both the
ﬁrmness and appearance of the repair tissue, as well as
its attachment. It is to be noted that our experiment was
designed to eliminate any potential differences between
proximal and distal locations and there was no signiﬁcant
difference for the arthroscopic parameters between the
proximal or distal defects. It also should be noted that cal-
ciﬁed cartilage was retained in all defects, in order to
address FDA concerns that beneﬁcial results from this
technique could be attributed to the ACI rather than com-
ing from subchondral elements. The PDS/PGA staples
were only partially cannulated (to enable insertion), and
therefore did not enable subchondral elements to migrate
into the defect site. In other work from the authors’ labora-
tory, it has been demonstrated that the normal healing re-
sponse for full-thickness defects is considerably inferior
when the calciﬁed cartilage is retained38. Based on the re-
sults of that study, removal of the calciﬁed cartilage with
debridement down to the subchondral bone plate could
potentially improve the quality of the repair tissue, as
well as the attachment of the repair tissue. On the other
hand, it is possible that retention of the calciﬁed cartilage
layer could have shielded the construct from an immune
response. The overall subjective tissue grade arthroscopi-
cally was fair to good, with the ACI treatment group having
the best average score.
As previously noted on histology that there was cellular
inﬁltration of the synovial membrane in both the CMA and
ACI groups, with a larger contribution coming from CMA
treatment (this was attained by comparing the joints with
no CMA treatment to the joints with CMA treatment). This
observation could imply that there is some reaction to the
porcine collagen membrane. We considered this inﬂamma-
tory cell inﬁltration to be clinically insigniﬁcant based on
what we see in equine clinical cases. Histological evalua-
tion of the repair tissue showed a signiﬁcant improvementin total histology scores with ACI compared to either CMA
or ECD treated defects and the repair tissue with ACI was
also graded as being more hyaline-like (all sections were
graded in a blind fashion). When quantitative histomorph-
ometry was performed, no statistical differences were ob-
served in repair tissue character. This may seem in conﬂict
with the subjective grading of tissue type a larger continuum
was used in determining tissue character with the subjective
grading of tissue type when compared to the histomorphom-
etry. The overall total histologic score is still valid in the au-
thors mind given only one component of this score
represented tissue character. Note that when considering
the differences between hyaline cartilages, only considering
percent ﬁlling by ﬁbrous tissue vs ﬁbrous cartilage vs hyaline
cartilage that the differences are insigniﬁcant both subjec-
tively and with quantitative histomorphometry.
Immunohistochemistry revealed signiﬁcantly more type II
collagen in the ACI and ECD defects compared to CMA de-
fects and there was signiﬁcantly more aggrecan noted in
the ACI group compared to either the CMA or ECD treated
defects. These ﬁndings are encouraging in that, in all previ-
ous studies done in the equine model, the type II collagen
content was relatively good for a full-thickness defect at
12 months and improved when subchondral microfracture
is done as well28,36, but the aggrecan content is usually
half that of normal articular cartilage and upregulating ag-
grecan content is a particular challenge28. In a recent study
looking at human cartilage biopsies 2 years after ACI, it was
shown that type II collagen mRNA content as well as aggre-
can mRNA expression was at lower levels in the treated
samples vs controls, but this is not surprising in view of
the 2-year time period and it would hardly be expected to
see upregulation of mRNA. However, the immunohisto-
chemistry results were rather confusing in that type II colla-
gen was found in all of the samples and conﬁned to the
cells, while controls showed positive diffuse staining in the
extra-cellular matrix39.
The histologic and immunohistochemistry results from this
long-term, randomized, histologically blinded large animal
GLP study are particularly encouraging suggesting superior-
ity with the ACI technique. There were no complications,
even with 18 months follow-up and rigorous physical rehabil-
itation. Although there is no comparable study published
with the traditional ACI technique in the horse (or with
such a large defect size in another animal model), the use
of a solid autologous cell-seeded construct implanted with
absorbable PDS/PGA staples would appear to offer consid-
erable clinical advantages.Acknowledgments
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